The Hepatitis A Vaccine Market is projected to grow significantly, rising from USD 0.92 billion in 2023 to reach USD 1.39 billion by 2031, registering a compound annual growth rate (CAGR) of 5.3% during the forecast period. The global rise in travel-related hepatitis A infections, growing awareness around liver health, and strong governmental vaccination initiatives are the primary forces...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek